1. Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer
   YOICHI MIZUTANI et al, 2012, International Journal of Oncology CrossRef
2. Mislocalization of Mitochondrial Intermembrane Space Proteins
   Lorna Flanagan et al, 2016, Mitochondria and Cell Death CrossRef
3. A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin
   Eugene K Lee et al, 2013, Cancer Biology & Therapy CrossRef
4. Targeting IAP proteins for therapeutic intervention in cancer
   Simone Fulda et al, 2012, Nature Reviews Drug Discovery CrossRef
5. OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients
   Guosen Zhang et al, 2019, Frontiers in Oncology CrossRef
6. IAPs on the move: role of inhibitors of apoptosis proteins in cell migration
   T K Oberoi-Khanuja et al, 2013, Cell Death & Disease CrossRef
7. Biomarkers for prognosis and treatment selection in advanced bladder cancer patients
   Yuanbin Ru et al, 2011, Current Opinion in Urology CrossRef
8. SMAC IAP Addiction in Cancer
   Matthew F. Brown et al, 2013, Cell Death Signaling in Cancer Biology and Treatment CrossRef
9. An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
   Yung-Chieh Chang et al, 2020, Applied Sciences CrossRef
10. Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
    Philipp Wolf, 2023, Frontiers in Oncology CrossRef
11. Molecular mechanisms of cisplatin resistance in bladder cancer
    Ross M Drayton et al, 2012, Expert Review of Anticancer Therapy CrossRef
12. Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
    Xiao-Yun Zhao et al, 2020, Cells CrossRef
13. Coexpression of Smac/DIABLO and Estrogen Receptor in breast cancer
    Magali Espinosa et al, 2021, Cancer Biomarkers CrossRef
14. Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
    Bozena Dobrzycka et al, 2011, Folia Histochemica et Cytobiologica CrossRef
15. Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer
    Thorsten H. Ecke, 2015, Advances in Cancer Biomarkers CrossRef
16. Apoptosis-Modulating Drugs for Improved Cancer Therapy
    M. Ocker et al, 2012, European Surgical Research CrossRef
17. Mitochondrial dysfunction and drug targets in multiple myeloma
    Yushan Cui et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef